DBV Technologies (DBVT) Receivables (2015 - 2023)
DBV Technologies (DBVT) posted quarterly Receivables of $1.4 million for Q4 2023, down 10.04% year-on-year from $1.5 million in Q4 2022, and down 10.04% on a QoQ basis from $1.5 million in Q4 2022.
DBV Technologies (DBVT) Receivables (2015 - 2023) Analysis & Trends
DBV Technologies (DBVT) has reported Receivables for 7 consecutive years, with $1.4 million the latest figure, recorded in Q4 2023.
- Quarterly Receivables fell 10.04% year-over-year to $1.4 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $1.4 million (down 10.04% YoY) and the FY2023 annual result came in at $1.4 million, down 10.04% from the prior year.
- Receivables eased to $1.4 million in Q4 2023 per DBVT's latest filing, from $1.5 million in the prior quarter.
- Over the last five years, Receivables for DBVT reached as high as $2.8 million in Q4 2020 and fell as low as $1.3 million in Q4 2021.
- A 4-year average of $1.7 million and a median of $1.4 million in 2022 frame the typical range for Receivables.
- Annual changes were most pronounced in 2021 — Receivables tumbled 54.39% — and 2022, when it advanced 17.32%.
- Year by year, Receivables stood at $2.8 million in 2020, then slumped by 54.39% to $1.3 million in 2021, then grew by 17.32% to $1.5 million in 2022, then retreated by 10.04% to $1.4 million in 2023.
- According to Business Quant data, Receivables over the past three periods registered $1.4 million, $1.5 million, and $1.3 million for Q4 2023, Q4 2022, and Q4 2021 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.35 Mn |
| Dec 31, 2022 | 1.50 Mn |
| Dec 31, 2021 | 1.28 Mn |
| Dec 31, 2020 | 2.81 Mn |
| Dec 31, 2017 | 3.55 Mn |
| Dec 31, 2016 | 4.54 Mn |
| Dec 31, 2015 | 2.05 Mn |